Abstract

B ecause of the hepatotrophic properties of portal flow,' preoperative selective portal vein embolization (PSPVE) may be a safe method to induce atrophy of the embolized portion of liver before resection and a compensatory hypertrophy in the future remnant liver. This technique recently has become important in the preoperative management of patients who must undergo extensive liver resection,2-4 improving operability and avoiding life-threatening postoperative liver failure5~~ when there is a risk for insufficient remaining liver parenchyma after surgery. In clinical practice, this can occur in cases of: (I) a small left lobe and the need for extended or normal right hepatectomy; (2) major liver surgery in patients with liver function impaired by cirrhosis, severe cholestasis, or primary or postchemotherapeutic secondary fibrosis; and (3) severe fatty steatosis. The fact that PSPVE is well tolerated might expand its indications in the future to increase the safety

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.